Austellus Medical Research And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 59464.48%
(FY 2023)
- Profit 205.55%
(FY 2023)
- Ebitda 4733.31%
(FY 2023)
- Net Worth 107601.18%
(FY 2023)
- Total Assets 458090.12%
(FY 2023)
About Austellus Medical Research And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sheeja Sachivan and Kanaran Sachivan serve as directors at the Company.
- CIN/LLPIN
U24304TN2020PTC135400
- Company No.
135400
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Austellus Medical Research And Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheeja Sachivan  | Director | 24-Jun-2021 | Current |
| Kanaran Sachivan | Director | 22-May-2020 | Current |
Financial Performance of Austellus Medical Research And Pharmaceuticals.
Austellus Medical Research And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59464.48% increase. The company also saw a substantial improvement in profitability, with a 205.55% increase in profit. The company's net worth Soared by an impressive increase of 107601.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Austellus Medical Research And Pharmaceuticals?
Unlock access to Austellus Medical Research And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Minami Metals Private LimitedActive 22 years 3 monthsSheeja Sachivan and Kanaran Sachivan are mutual person
Pentaprime Agro And Trading Private LimitedActive 4 years 5 monthsSheeja Sachivan and Kanaran Sachivan are mutual person
- P K S Holdings & Investments Private LimitedActive 16 years 6 months
Sheeja Sachivan and Kanaran Sachivan are mutual person
- Zentan Consultancy Private LimitedActive 3 years 9 months
Sheeja Sachivan and Kanaran Sachivan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Austellus Medical Research And Pharmaceuticals?
Austellus Medical Research And Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Austellus Medical Research And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Austellus Medical Research And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
